Details
Stereochemistry | ACHIRAL |
Molecular Formula | C25H20N4O5 |
Molecular Weight | 456.4501 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC1=NC2=C(N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NOC(=O)N5)C(=CC=C2)C(O)=O
InChI
InChIKey=KGSXMPPBFPAXLY-UHFFFAOYSA-N
InChI=1S/C25H20N4O5/c1-2-33-24-26-20-9-5-8-19(23(30)31)21(20)29(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-27-25(32)34-28-22/h3-13H,2,14H2,1H3,(H,30,31)(H,27,28,32)
Molecular Formula | C25H20N4O5 |
Molecular Weight | 456.4501 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:56:11 UTC 2023
by
admin
on
Fri Dec 15 15:56:11 UTC 2023
|
Record UNII |
F9NUX55P23
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175561
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
||
|
NCI_THESAURUS |
C66930
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
||
|
LIVERTOX |
NBK548036
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL57242
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
m2173
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | Merck Index | ||
|
135415867
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
TT-131
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
Azilsartan
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
8724
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
N0000178477
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | Decreased Blood Pressure [PE] | ||
|
68850
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
147403-03-0
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
SUB31561
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
DTXSID70163712
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
C521273
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
1091643
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | RxNorm | ||
|
F9NUX55P23
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
F9NUX55P23
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
DB08822
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
N0000180999
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | Angiotensin 2 Type 1 Receptor Antagonists [MoA] | ||
|
100000124198
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
C75107
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
8208
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY | |||
|
AZILSARTAN
Created by
admin on Fri Dec 15 15:56:11 UTC 2023 , Edited by admin on Fri Dec 15 15:56:11 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
TARGET -> INHIBITOR |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
Probable human carcinogen.
|
||
|
IMPURITY -> PARENT |
Priority toxic pollutant.
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY GENOTOXIC->PARENT |
NDMA is an organic chemical that is in a family of potent carcinogens.
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||